XKRX
024720
Market cap240mUSD
Oct 08, Last price
9,400.00KRW
1D
1.40%
1Q
12.04%
Jan 2017
-72.11%
IPO
186.41%
Name
Kolmar Korea Holdings Co Ltd
Chart & performance
P/E
13.76
P/S
0.51
EPS
683.32
Div yield, %
2.66%
Shrs. gr., 5y
13.10%
Rev. gr., 5y
-1.38%
Revenues
630.11b
-6.88%
Net income
23.44b
-4.61%
CFO
31.03b
-21.46%
Dividend
Mar 26, 2026220 KRW/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Kolmar Korea Holdings Co., Ltd. is engaged in the manufacturing and global distribution of cosmetics, pharmaceutical products, and nutritional supplements, serving markets both within South Korea and internationally. Its comprehensive range of beauty offerings includes skincare, makeup, haircare, body care, and products designed for infants, alongside specialized functional cosmetics and fragrances. Furthermore, the company provides over-the-counter medications and dietary aids. Founded in 1990, its main corporate headquarters are situated in Sejong City, South Korea.
Key people
Chairman of the Board · since 2019
Non-Executive Independent Director · since 2012
Sang Heon Jang
Non-Executive Independent Director · since 2012
Headquarters & legal address
세종특별자치시 전의면 덕고개길 12-11
콜마홀딩스 주식회사
Sejong Special Autonomous City, 50 30004
KR
콜마홀딩스 주식회사
Sejong Special Autonomous City, 50 30004
KR
Address
12-11, Deokgogae-gil, Jeonui-myeon, Sejong-si
KOLMAR HOLDINGS CO., LTD.
Sejong Special Autonomous City, 50 30004
KR
KOLMAR HOLDINGS CO., LTD.
Sejong Special Autonomous City, 50 30004
KR
Previous name
한국콜마홀딩스 주식회사
Other language
KOLMAR HOLDINGS CO., LTD.
Valuation
Title KRW in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||